We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£520.00
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 3 months
Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 17 days · 17 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 17 days • 1 price levels
Price Analysis
Most common price: £520 (17 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 17 days
Description
Key Features
Provides latent demand estimates in millions of U.S. dollars for pulmonary fibrosis treatments across the United States.
Includes potential industry earnings (P.I.E.) data for approximately 12,600 cities to assist in market analysis.
Reports the percent share of each city relative to its state and the entire United States for comparative benchmarking.
Supports the development of distribution and sales force strategies through detailed statistical data.
Covers the outlook period from 2023 through 2028 for the United States pulmonary fibrosis treatment market.
Product Specifications
- Format
- paperback
- ASIN
- B0BLQYMQHP
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 10 November 2022
Similar Products You Might Like
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China
The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments
Price unavailable
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis
The 2025-2030 World Outlook for Pulmonary Fibrosis Treatments
Price unavailable
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
Price unavailable
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis
Price unavailable
The 2023 Report on Idiopathic Pulmonary Fibrosis: World Market Segmentation by City
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes
The 2025-2030 World Outlook for Anti-Idiopathic Pulmonary Fibrosis Drugs
Price unavailable
The 2013-2018 Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics in India
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
The 2016-2021 World Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics
US Respiratory Disorder Treatment Outlook 2023-2028 Study
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
India Respiratory Disorder Treatment Outlook 2023-2028 Study
The 2025-2030 World Outlook for Cystic Fibrosis Therapeutics
Price unavailable